As of June 15, 2025, PW Medtech Group Ltd (1358.HK) reports a Current Ratio of 11.80.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of PW Medtech Group Ltd's Current Ratio
Over recent years, PW Medtech Group Ltd's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-12-31 | 11.80 |
| 2023-12-31 | 13.61 |
| 2022-12-31 | 11.59 |
| 2021-12-31 | 24.82 |
| 2020-12-31 | 29.62 |
This slight downward trend highlights how PW Medtech Group Ltd manages its short-term assets and liabilities over time.
Comparing PW Medtech Group Ltd's Current Ratio to Peers
To better understand PW Medtech Group Ltd's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| PW Medtech Group Ltd (1358.HK) | 11.80 |
| Chison Medical Technologies Co Ltd (688358.SS) | 8.42 |
| Beijing Wandong Medical Technology Co Ltd (600055.SS) | 8.32 |
| Guangzhou LBP Medicine Science & Technology Co Ltd (688393.SS) | 8.19 |
| Nanjing Vishee Medical Technology Co Ltd (688580.SS) | 6.07 |
| Andon Health Co Ltd (002432.SZ) | 5.50 |
Compared to its competitors, PW Medtech Group Ltd's Current Ratio is higher than all peers, indicating strong short-term financial flexibility but potentially excess cash that could be invested.